These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 27450097)
1. Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease. Zhang Y; Zhang X; Liu D; Wang H; Pan S; Wang D; Chen X Neurol Sci; 2016 Nov; 37(11):1823-1829. PubMed ID: 27450097 [TBL] [Abstract][Full Text] [Related]
2. Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica. Masuda H; Mori M; Uzawa A; Muto M; Uchida T; Kuwabara S Eur J Neurol; 2016 Feb; 23(2):276-81. PubMed ID: 25903772 [TBL] [Abstract][Full Text] [Related]
3. Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica. Yang T; Wang S; Zheng Q; Wang L; Li Q; Wei M; Du Z; Fan Y BMC Neurol; 2016 Jul; 16():96. PubMed ID: 27401736 [TBL] [Abstract][Full Text] [Related]
4. Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis. Shu Y; Li R; Qiu W; Chang Y; Sun X; Fang L; Chen C; Yang Y; Lu Z; Hu X; Kermode AG Mult Scler Relat Disord; 2017 Nov; 18():65-70. PubMed ID: 29107207 [TBL] [Abstract][Full Text] [Related]
5. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Chitnis T; Ness J; Krupp L; Waubant E; Hunt T; Olsen CS; Rodriguez M; Lotze T; Gorman M; Benson L; Belman A; Weinstock-Guttman B; Aaen G; Graves J; Patterson M; Rose JW; Casper TC Neurology; 2016 Jan; 86(3):245-52. PubMed ID: 26683648 [TBL] [Abstract][Full Text] [Related]
6. Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients. Kusumadewi W; Imran D; Witjaksono F; Pakasi TA; Rusmana AI; Pangeran D; Marwadhani SS; Maharani K; Estiasari R Mult Scler Relat Disord; 2018 Oct; 25():329-333. PubMed ID: 30195201 [TBL] [Abstract][Full Text] [Related]
7. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica. Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387 [TBL] [Abstract][Full Text] [Related]
8. Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica. Farrokhi M; Rezaei A; Amani-Beni A; Etemadifar M; Kouchaki E; Zahedi A Acta Neurol Belg; 2015 Dec; 115(4):609-14. PubMed ID: 26008726 [TBL] [Abstract][Full Text] [Related]
9. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis. Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373 [TBL] [Abstract][Full Text] [Related]
10. Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis. Wang KC; Lee CL; Chen SY; Chen JC; Yang CW; Chen SJ; Tsai CP J Interferon Cytokine Res; 2013 Feb; 33(2):58-64. PubMed ID: 23398365 [TBL] [Abstract][Full Text] [Related]
11. Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse. Wang H; Wang K; Zhong X; Dai Y; Wu A; Li Y; Hu X J Neuroimmunol; 2012 Feb; 243(1-2):52-5. PubMed ID: 22177277 [TBL] [Abstract][Full Text] [Related]
12. Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica. Akaishi T; Nakashima I; Misu T; Fujihara K; Aoki M J Neuroimmunol; 2015 Jun; 283():70-3. PubMed ID: 26004160 [TBL] [Abstract][Full Text] [Related]
13. Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica. Wang H; Wang K; Wang C; Zhong X; Qiu W; Hu X Mult Scler; 2013 Jun; 19(7):926-31. PubMed ID: 23012252 [TBL] [Abstract][Full Text] [Related]
14. Elevated soluble syndecan-1 levels in neuromyelitis optica are associated with disease severity. Pei S; Zheng D; Wang Z; Hu X; Pan S; Wang H Cytokine; 2018 Nov; 111():140-145. PubMed ID: 30142535 [TBL] [Abstract][Full Text] [Related]
15. Movement disorders in multiple sclerosis and neuromyelitis optica: A clinical marker of neurological disability. Candeias da Silva C; Bichuetti DB; Azevedo Silva SMC; Ferraz HB; Oliveira EML; Borges V Parkinsonism Relat Disord; 2018 Jun; 51():73-78. PubMed ID: 29530725 [TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability. Tomizawa Y; Yokoyama K; Saiki S; Takahashi T; Matsuoka J; Hattori N J Int Med Res; 2012; 40(4):1483-91. PubMed ID: 22971500 [TBL] [Abstract][Full Text] [Related]
17. Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse. Shu Y; Li R; Yang Y; Dai Y; Qiu W; Chen Y; Zhao Z; Lu Z; Hu X Neurochem Int; 2015 Feb; 81():28-31. PubMed ID: 25555815 [TBL] [Abstract][Full Text] [Related]
18. Corticospinal tract integrity measured using transcranial magnetic stimulation and magnetic resonance imaging in neuromyelitis optica and multiple sclerosis. Manogaran P; Vavasour I; Borich M; Kolind SH; Lange AP; Rauscher A; Boyd L; Li DK; Traboulsee A Mult Scler; 2016 Jan; 22(1):43-50. PubMed ID: 25948623 [TBL] [Abstract][Full Text] [Related]
19. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica. Wegner C Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis. Warabi Y; Yagi K; Hayashi H; Matsumoto Y J Neurol Sci; 2006 Nov; 249(2):145-52. PubMed ID: 16860825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]